{"id":47700,"date":"2023-12-13T17:47:32","date_gmt":"2023-12-13T16:47:32","guid":{"rendered":"https:\/\/www.cmtc.nl\/blog\/2023\/12\/13\/belangrijk-nieuws-over-sirolimus\/"},"modified":"2025-02-25T12:29:02","modified_gmt":"2025-02-25T11:29:02","slug":"important-news-about-sirolimus","status":"publish","type":"post","link":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/","title":{"rendered":"Important news about sirolimus"},"content":{"rendered":"<p>In a groundbreaking development, the interim analysis of the large multicenter Phase III VASE (Vascular Anomaly-Sirolimus Europe) trial, using sirolimus (Rapamune from Pfizer), to address slow-flow vascular malformations has been published in JCI Insight. This marks a significant milestone in the ongoing study and provides insight into the potential efficacy of this treatment.<\/p>\n<p><a href=\"https:\/\/www.cmtc.nl\/en\/pedia\/pedia-other\/sirolimus\/exciting-interim-results-from-phase-iii-trial-vase-sirolimus-shows-promise-in-managing-vascular-malformations\/\" target=\"_blank\" rel=\"noopener\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a groundbreaking development, the interim analysis of the large multicenter Phase III VASE (Vascular Anomaly-Sirolimus Europe) trial, using sirolimus (Rapamune from Pfizer), to address slow-flow vascular malformations has been published in JCI Insight. This marks a significant milestone in the ongoing study and provides insight into the potential efficacy of this treatment. Read more<\/p>\n","protected":false},"author":2,"featured_media":47679,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[297],"tags":[],"class_list":["post-47700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Important news about sirolimus - CMTC-OVM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Important news about sirolimus - CMTC-OVM\" \/>\n<meta property=\"og:description\" content=\"In a groundbreaking development, the interim analysis of the large multicenter Phase III VASE (Vascular Anomaly-Sirolimus Europe) trial, using sirolimus (Rapamune from Pfizer), to address slow-flow vascular malformations has been published in JCI Insight. This marks a significant milestone in the ongoing study and provides insight into the potential efficacy of this treatment. Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\" \/>\n<meta property=\"og:site_name\" content=\"CMTC-OVM\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-13T16:47:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-25T11:29:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lex van der Heijden\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lex van der Heijden\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\"},\"author\":{\"name\":\"Lex van der Heijden\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f\"},\"headline\":\"Important news about sirolimus\",\"datePublished\":\"2023-12-13T16:47:32+00:00\",\"dateModified\":\"2025-02-25T11:29:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\"},\"wordCount\":59,\"image\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg\",\"articleSection\":[\"Latest news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\",\"url\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\",\"name\":\"Important news about sirolimus - CMTC-OVM\",\"isPartOf\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg\",\"datePublished\":\"2023-12-13T16:47:32+00:00\",\"dateModified\":\"2025-02-25T11:29:02+00:00\",\"author\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage\",\"url\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg\",\"contentUrl\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg\",\"width\":1280,\"height\":853},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cmtc.nl\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Important news about sirolimus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/#website\",\"url\":\"https:\/\/www.cmtc.nl\/en\/\",\"name\":\"CMTC-OVM\",\"description\":\"Global non-profit patient organisation\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cmtc.nl\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f\",\"name\":\"Lex van der Heijden\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g\",\"caption\":\"Lex van der Heijden\"},\"description\":\"Father of a daughter with CMTC. Founder and President of the CMTC-OVM organisation. Former Senior Project Manager IBM Global Services.\",\"sameAs\":[\"https:\/\/www.cmtc.nl\/\"],\"url\":\"https:\/\/www.cmtc.nl\/en\/blog\/author\/lex\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Important news about sirolimus - CMTC-OVM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/","og_locale":"en_US","og_type":"article","og_title":"Important news about sirolimus - CMTC-OVM","og_description":"In a groundbreaking development, the interim analysis of the large multicenter Phase III VASE (Vascular Anomaly-Sirolimus Europe) trial, using sirolimus (Rapamune from Pfizer), to address slow-flow vascular malformations has been published in JCI Insight. This marks a significant milestone in the ongoing study and provides insight into the potential efficacy of this treatment. Read more","og_url":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/","og_site_name":"CMTC-OVM","article_published_time":"2023-12-13T16:47:32+00:00","article_modified_time":"2025-02-25T11:29:02+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg","type":"image\/jpeg"}],"author":"Lex van der Heijden","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lex van der Heijden","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#article","isPartOf":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/"},"author":{"name":"Lex van der Heijden","@id":"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f"},"headline":"Important news about sirolimus","datePublished":"2023-12-13T16:47:32+00:00","dateModified":"2025-02-25T11:29:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/"},"wordCount":59,"image":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg","articleSection":["Latest news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/","url":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/","name":"Important news about sirolimus - CMTC-OVM","isPartOf":{"@id":"https:\/\/www.cmtc.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage"},"image":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg","datePublished":"2023-12-13T16:47:32+00:00","dateModified":"2025-02-25T11:29:02+00:00","author":{"@id":"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f"},"breadcrumb":{"@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#primaryimage","url":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg","contentUrl":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2023\/12\/medicine-5329776_1280.jpg","width":1280,"height":853},{"@type":"BreadcrumbList","@id":"https:\/\/www.cmtc.nl\/en\/blog\/2023\/12\/13\/important-news-about-sirolimus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cmtc.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Important news about sirolimus"}]},{"@type":"WebSite","@id":"https:\/\/www.cmtc.nl\/en\/#website","url":"https:\/\/www.cmtc.nl\/en\/","name":"CMTC-OVM","description":"Global non-profit patient organisation","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cmtc.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.cmtc.nl\/en\/#\/schema\/person\/fae194c6ccc4c847d931396c118a0b7f","name":"Lex van der Heijden","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/048d3445f0c653122a4ffb542f66ffe120bde7d60ba1496b6bac440d25817b8d?s=96&d=mm&r=g","caption":"Lex van der Heijden"},"description":"Father of a daughter with CMTC. Founder and President of the CMTC-OVM organisation. Former Senior Project Manager IBM Global Services.","sameAs":["https:\/\/www.cmtc.nl\/"],"url":"https:\/\/www.cmtc.nl\/en\/blog\/author\/lex\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/posts\/47700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/comments?post=47700"}],"version-history":[{"count":2,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/posts\/47700\/revisions"}],"predecessor-version":[{"id":62691,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/posts\/47700\/revisions\/62691"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/media\/47679"}],"wp:attachment":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/media?parent=47700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/categories?post=47700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/tags?post=47700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}